|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.57 CNY | -2.05% |
|
-3.24% | -25.23% |
| 04-19 | Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-29 | Teyi Pharmaceutical Group Co.,Ltd Approves the Cash Dividend for 2023 | CI |
Teyi Pharmaceutical Group Co.,Ltd reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 538.38 million compared to CNY 385.14 million a year ago. Net income was CNY 152.13 million compared to CNY 61.46 million a year ago.
Basic earnings per share from continuing operations was CNY 0.3357 compared to CNY 0.1429 a year ago. Diluted earnings per share from continuing operations was CNY 0.3286 compared to CNY 0.1429 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -25.23% | 677M | |
| +30.78% | 595B | |
| -2.60% | 367B | |
| +20.83% | 334B | |
| +5.69% | 289B | |
| +14.34% | 239B | |
| +9.61% | 211B | |
| -2.74% | 203B | |
| +10.77% | 171B | |
| +0.10% | 163B |
TEYI PHARMACEUTICAL GROUP CO.,LTD 
